Clinical trial
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Recruiting now · Early Phase 1 · 1 countries · Registry ID NCT04838678
What this study is about
The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.
Basic eligibility
Full registry criteria
Treatments and study arms
Neuropeptide Y
intra-arterial infusion of neuropeptide Y
Primary outcomes
brachial and femoral artery blood flow
recording of sympathetic nervous system activity from the peroneal or radial nerve
Study locations
1 locations were listed when this page was built. The first 40 are shown.